Other substances

Haloperidol

A postsynaptic dopamine (D2) receptor blocker.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

2
 Supporting references
0
 Contradictory references
4
 AI-suggested references
0
 Clinical trials

General information

Haloperidol on PubChem

Marketed as

ALOPERIDIN; BIOPERIDOLO; BROTOPON; DOZIC; DURAPERIDOL; EINALON S; EUKYSTOL; HALDOL; HALOPERIDOL; HALOSTEN; KESELAN; LINTON; PELUCES; SERENACE; SIGAPERIDOL

 

Structure image - Haloperidol

C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F

Supporting references

Link Tested on Impact factor Notes Publication date
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Small molecule 		in silico 42.78 Apr/30/2020
Insights into the biased activity of dextromethorphan and haloperidol towards SARS-CoV-2 NSP6: in silico binding mechanistic analysis
nsp6 Small molecule In silico 		in silico 4.43

Predicted to bind the SARS-CoV-2 nsp6 protein.

 Sep/23/2020

AI-suggested references

Link Publication date
Pediatric COVID-19 Delirium: Case Report of 2 Adolescents.
Mar/10/2022
Observational study of haloperidol in hospitalized patients with COVID-19
May/03/2022
SARS-CoV-2 orf1b Gene Sequence in the NTNG1 Gene on Human Chromosome 1.
May/03/2020
On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2.
Aug/19/2020
Export (.csv)